Green Alpha Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
QCM
NAMA
Green Alpha Advisors's TXG Position: Q2 2026 in Review
Green Alpha Advisors opened a new position in 10x Genomics (TXG) in Q2 2026: 8,372 shares worth $321K. The stake represents 0.22% of the portfolio and ranks #83 among its holdings. This is a return to the name: Green Alpha Advisors previously reported a position in TXG as recently as Q4 2025.
Green Alpha Advisors first reported a position in TXG in Q1 2021 and has held it in 19 quarters since. The position peaked at $1.06M in Q2 2021. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.
- Green Alpha Advisors held 8,372 shares of 10x Genomics worth $321K as of Q2 2026.
- 10x Genomics was a new Green Alpha Advisors position in Q2 2026.
- 10x Genomics made up 0.22% of Green Alpha Advisors's portfolio in Q2 2026, its #83 holding.
- Green Alpha Advisors first reported a position in 10x Genomics in Q1 2021 and has held it in 19 quarters since.
- Green Alpha Advisors's 10x Genomics position peaked at $1.06M in Q2 2021.
- 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.
Based on Green Alpha Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.